Calvin Sternick

Stock Analyst at JP Morgan

(2.02)
# 3,072
Out of 5,152 analysts
19
Total ratings
46.15%
Success rate
7.03%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $82.63
Upside: +33.12%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $43.27
Upside: +84.89%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $35.57
Upside: -24.09%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $196.96
Upside: -7.60%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $241.40
Upside: -66.45%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $147.71
Upside: +165.38%